PBMs are Clear as Mud: The Value of a Fee-Based, Transparent Model
Transparency in the drug supply chain is desperately needed to deliver consumers the lowest cost and highest value prescription drugs.
Transparency in the drug supply chain is desperately needed to deliver consumers the lowest cost and highest value prescription drugs.
In this issue brief, ACHP identifies policy solutions to improve provider directories, reducing provider burden and ensuring directories are useful for consumers.
The Connecting to Coverage Coalition (CCC) represents a diverse collection of stakeholders, including ACHP, partnering to minimize disruptions in health coverage associated with the resumption of state Medicaid renewals.
To ensure the use of AI technology in health care will improve patient outcomes and create a more sustainable and accessible health care system, public policy must support its innovation and safe use.
Health equity is a core priority for ACHP members, but the new Health Equity Index (HEI) reward may end up creating a dilemma for some of the health plans most invested in its success.